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INTRODUCTION
• Staphylococcus aureus infections have 
become a worldwide threat.
• Numbers of total hospital acquired infections 
with MRSA/ORSA have decreased since the 
introduction of appropriate infection control 
procedures.
• However, the ability of Staphylococcus aureus 
to adapt has lead to increasing rates of 
community acquired infections despite 
reduction in the rates of Hospital-acquired 
infections. 
METHODS
Purpose: 
• Trend the Prevalence of resistant 
Staphylococcus aureus infections in patients 
presenting to medical facilities across four 
geographically distinct  areas of the United 
States
• Compare the incidence of resistant 
Staphylococcus aureus infections between 
pediatric and adult populations
Study Design:
• Retrospective data review and longitudinal 
analysis of 82,500 adult charts and 15,215 
pediatric charts from the Cerner electronic 
record database. 
Inclusion criteria:
• Infections classified as “community acquired” 
between 2000-2013
• Patients from both sexes, all ages, all payer 
types. 
Exclusion criteria:
• Infections classified as “hospital-acquired” 
between 2000-2013
• Incomplete data (i.e. records missing such as 
age, sex, payer type, Staphylococcal infection 
isolate)
Statistical Tests: 
• Descriptive statistics using Microsoft Excel 
• Cerner data supports a declining  trend in total 
recorded MRSA/ORSA infections from 2000 to 
2013.
• The percentage of MRSA/ORSA infections has 
increased in all populations, especially in the 
pediatric population and in southern regions. 
• Multiple factors that can lead to the spread of 
Staphylococcus in the community based 
population.
• To gain a better understanding of the data 
trends showing a percentage increase in the 
MRSA infections of pediatrics further research 
evaluating the risks is needed. 
Adult MRSA/ORSA Cases from 2000-2013
Total S. aureus infections in adult and pediatric populations by year
• As suggested by previous research we also were able to see 
that the data from Cerner showed an overall declining trend 
among total number of Staphylococcus aureus infections in 
both the resistant and susceptible groups from 2000 -2013.
Percent MRSA/ORSA in Pediatric cases
Percent resistant per region
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Data suggests the rate of resistant infections in the pediatric 
population increased from 2000 to 2013. It has risen from 8.6%
of cases in 2000 to 30.9% of cases in 2013. 
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• The Southern region shows the highest rate of MRSA/ORSA
infections in both adult and pediatric populations. 
• Demographic information to help better define these populations 
was not pulled during initial questioning
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